What are the chances of Relay Therapeutics Inc (RLAY) Stock turning the corner?
Jefferies raised the price target for the Relay Therapeutics Inc (NASDAQ:RLAY) stock from “an Underperform” to “a Hold”. The rating was released on April 20, 2023, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was initiated by Oppenheimer, who […]
Relay Therapeutics Inc (RLAY) Stock Still Strong Despite Competition
Jefferies raised the price target for the Relay Therapeutics Inc (NASDAQ:RLAY) stock from “an Underperform” to “a Hold”. The rating was released on April 20, 2023, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was initiated by Oppenheimer, who […]
There Is Nothing Like Relay Therapeutics Inc (RLAY) Stock
Jefferies raised the price target for the Relay Therapeutics Inc (NASDAQ:RLAY) stock from “an Underperform” to “a Hold”. The rating was released on April 20, 2023, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was initiated by Oppenheimer, who […]
Consensus Analyst Estimated Price Target of $23.05 for Relay Therapeutics Inc (NASDAQ:RLAY) Stock
Jefferies raised the price target for the Relay Therapeutics Inc (NASDAQ:RLAY) stock from “an Underperform” to “a Hold”. The rating was released on April 20, 2023, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was initiated by Oppenheimer, who […]
Relay Therapeutics Inc (RLAY) Stock at a key inflection point
Jefferies raised the price target for the Relay Therapeutics Inc (NASDAQ:RLAY) stock from “an Underperform” to “a Hold”. The rating was released on April 20, 2023, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was initiated by Oppenheimer, who […]
The growth of Relay Therapeutics Inc (RLAY) Stock is expected to continue
Jefferies raised the price target for the Relay Therapeutics Inc (NASDAQ:RLAY) stock from “an Underperform” to “a Hold”. The rating was released on April 20, 2023, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was initiated by Oppenheimer, who […]
Jefferies raised the price target for the Relay Therapeutics Inc (NASDAQ:RLAY) stock to “”a Hold””
Jefferies raised the price target for the Relay Therapeutics Inc (NASDAQ:RLAY) stock from “an Underperform” to “a Hold”. The rating was released on April 20, 2023, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was initiated by Oppenheimer, who […]
